Finance

Lists
000020:KRX
Dongwha Pharm Co Ltd
â‚©5,180.00
+1.77%
(+90.00) 1D
Aug 28, 3:30:14 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 000020...
Open
â‚©5,120
High
â‚©5,180
Low
â‚©5,070
Mkt. cap
144.69B
Avg. vol.
582.06K
Volume
67.10K
Dividend
1.25%
Quarterly dividend
â‚©16
Ex-dividend date
Dec 27, 2024
P/E ratio
7.69
52-wk high
â‚©7,560
52-wk low
â‚©4,450
EPS
â‚©674
Shares outstanding
27.93M
No. of employees
826
Open
â‚©5,120
High
â‚©5,180
Low
â‚©5,070
Mkt. cap
144.69B
Avg. vol.
582.06K
Volume
67.10K
Dividend
1.25%
Quarterly dividend
â‚©16
Ex-dividend date
Dec 27, 2024
P/E ratio
7.69
52-wk high
â‚©7,560
52-wk low
â‚©4,450
EPS
â‚©674
Shares outstanding
27.93M
No. of employees
826
About Dongwha Pharm Co Ltd
CEOYoo Jun-ha | Han Jong-hyun
Employees826
FoundedSep 25, 1897
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
122.00B
123.70B
130.61B
136.93B
Cost of goods sold
67.03B
71.57B
70.80B
77.61B
Cost of revenue
67.03B
71.57B
70.80B
77.61B
Research and development expenses
1.73B
20.32B
5.42B
6.51B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
47.10B
33.31B
39.80B
39.78B
Operating expense
53.60B
56.63B
48.58B
49.03B
Total operating expenses
120.63B
128.19B
119.39B
126.64B
Operating income
1.37B
-4.50B
11.23B
10.29B
Other non operating income
641.83M
-65.61M
892.29M
810.33M
EBT including unusual items
875.23M
-4.88B
8.07B
7.93B
EBT excluding unusual items
1.52B
-5.68B
10.74B
10.13B
Income tax expense
633.61M
-3.15B
-1.58B
1.47B
Effective tax rate
72.39%
64.47%
-19.64%
18.49%
Other operating expenses
628.08M
154.48M
510.81M
-342.78M
Net income
957.13M
454.02M
10.02B
6.65B
Net profit margin
0.78%
0.37%
7.67%
4.85%
Earnings per share
-
-
-
-
Interest and investment income
1.10B
382.40M
272.32M
456.60M
Interest expense
-1.30B
-1.47B
-1.42B
-1.45B
Net interest expenses
-206.66M
-1.09B
-1.14B
-997.70M
Depreciation and amortization charges
2.95B
1.09B
2.23B
2.29B
EBITDA
7.02B
1.28B
16.74B
15.87B
Gain or loss from assets sale
-2.36M
11.97M
-18.54M
-63.85M
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps